Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T86462 | Target Info | |||
Target Name | Transthyretin (TTR) | ||||
Synonyms | TBPA; Prealbumin; PALB; ATTR | ||||
Target Type | Successful Target | ||||
Gene Name | TTR | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Luteolin | Ligand Info | |||
Canonical SMILES | C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)O | ||||
InChI | 1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H | ||||
InChIKey | IQPNAANSBPBGFQ-UHFFFAOYSA-N | ||||
PubChem Compound ID | 5280445 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 4DEW Crystal Structure of the Wild Type TTR Binding Luteolin (TTRwt:LUT) | ||||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | No | [1] |
PDB Sequence |
CPLMVKVLDA
19 VRGSPAINVA29 VHVFRKAADD39 TWEPFASGKT49 SESGELHGLT59 TEEEFVEGIY 69 KVEIDTKSYW79 KALGISPFHE89 HAEVVFTAND99 SGPRRYTIAA109 LLSPYSYSTT 119 AVVTNP
|
|||||
|
||||||
PDB ID: 4QXV CRYSTAL STRUCTURE of HUMAN TRANSTHYRETIN IN COMPLEX WITH LUTEOLIN AT 1.1 A RESOLUTION | ||||||
Method | X-ray diffraction | Resolution | 1.12 Å | Mutation | No | [2] |
PDB Sequence |
CPLMVKVLDA
19 VRGSPAINVA29 VHVFRKAADD39 TWEPFASGKT49 SESGELHGLT59 TEEEFVEGIY 69 KVEIDTKSYW79 KALGISPFHE89 HAEVVFTAND99 SGPRRYTIAA109 LLSPYSYSTT 119 AVVTNP
|
|||||
|
||||||
PDB ID: 4QYA Crystal structure of human transthyretin variant V30M in complex with luteolin | ||||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | Yes | [2] |
PDB Sequence |
CPLMVKVLDA
19 VRGSPAINVA29 MHVFRKAADD39 TWEPFASGKT49 SESGELHGLT59 TEEEFVEGIY 69 KVEIDTKSYW79 KALGISPFHE89 HAEVVFTAND99 SGPRRYTIAA109 LLSPYSYSTT 119 AVVTNP
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Flavonoid interactions with human transthyretin: combined structural and thermodynamic analysis. J Struct Biol. 2012 Oct;180(1):143-53. | ||||
REF 2 | The flavonoid luteolin, but not luteolin-7-O-glucoside, prevents a transthyretin mediated toxic response. PLoS One. 2015 May 28;10(5):e0128222. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.